Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Navistar International Corp (NAV), PACCAR Inc (PCAR): Which Names to Buy Amid an Improving Truck Market

Page 1 of 2

The trucking industry has been in the news recently, especially after the market viewed some optimism in the last earnings season. Performance of this industry is important, as it is a leading indicator of the health of the economy. Recently, some numbers relevant to the trucking industry were released, which can help us understand the industry’s performance.

Navistar International Corp (NYSE:NAV)

Positive numbers

ACT Research released NAFTA original equipment manufacturer (OEM) build and retail sales data for the month of May, with industry builds coming in at 23,300, up from 22,700 in April but still down from 27,400 in May 2012. May represents the fifth-consecutive month of sequential growth in Class 8 builds (+2.5% month-over-month on a sequential basis). The May data is supportive of the view of a relatively healthy, replacement-driven NAFTA Class 8 market.

Moreover, it suggests that the gradual improvements in monthly build rates thus far in 2013 reflect a NAFTA Class 8 market that seems to be on somewhat firmer footing following a period of choppy/declining builds. Class 8 backlog was flat at 85,800 (vs. 85,700 in April), reflecting order and build rates that have generally trended inline with one another over the past several months and supporting the point of view that orders will need to remain at least in the low 20,000/month range to maintain current backlog levels.

Which companies will benefit?

Positive numbers tell us that the industry is gradually improving but it doesn’t tell us which companies are performing well. Let’s have a look:

Navistar (NYSE:NAV)’s Class 8 retail sales share for May was 12.5% (down from 13.9% in April). Although it is important for Navistar to demonstrate some progress on driving market share improvements over time, it is not unusual for Navistar International Corp (NYSE:NAV) to have a decline in market share in the first month of its fiscal quarter (Navistar’s retail sales share has declined in May in seven out of the previous 10 years, with an average decline of 140 bps over that time period matching the decline in this month’s data).

Hence, Navistar International Corp (NYSE:NAV)’s share could remain subdued/choppy in the near term, but the market is cautiously optimistic that as FY 2013 progresses, and especially in FY 2014, Navistar International Corp (NYSE:NAV) could continue to gradually ramp-up production and retail share with its Cummins Inc. (NYSE:CMI)’s ISX15L-equipped ProStar as well as with its proprietary 13L-equipped ProStar.

Cummins – The savior

And who can forget Navistar’s disastrous engine strategy employed by former CEO Dan Ustian? It was in April that Navistar was finally able to solve its engine problems. The truck maker announced that the Environmental Protection Agency (EPA) had finally blessed the company’s 13-liter engine, which paved the way for customer delivery to begin by April’s end.

This wasn’t some trivial matter for Navistar International Corp (NYSE:NAV), which in the last year and a half ran dead smack into regulatory and legal issues that threatened the life of the company. For those not familiar with the story, Navistar made a big bet on an engine design that failed to win EPA approval and as it started running low on emission “credits,” there was a thought Navistar International Corp (NYSE:NAV) might have to shut down its engine line.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!